Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
Rules-Based Medicine, Inc. (RBM), the world’s leading multiplexed biomarker testing laboratory, announced the launch of its Human Kidney Multi-Analyte Profile (MAP), a cost-effective biomarker testing service designed to aid pharmaceutical and biotechnology companies in their efforts to improve drug development through better understanding of drug toxicity.
More: continued here
Filed under: Urology on January 16th, 2009